CN103920190B - 一种关节软骨移植物及其制备方法 - Google Patents
一种关节软骨移植物及其制备方法 Download PDFInfo
- Publication number
- CN103920190B CN103920190B CN201310012363.2A CN201310012363A CN103920190B CN 103920190 B CN103920190 B CN 103920190B CN 201310012363 A CN201310012363 A CN 201310012363A CN 103920190 B CN103920190 B CN 103920190B
- Authority
- CN
- China
- Prior art keywords
- cartilage
- layer
- cell
- shallow
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000001188 articular cartilage Anatomy 0.000 title claims abstract description 84
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 210000000845 cartilage Anatomy 0.000 claims abstract description 98
- 210000003321 cartilage cell Anatomy 0.000 claims abstract description 81
- 102000002734 Collagen Type VI Human genes 0.000 claims abstract description 43
- 108010043741 Collagen Type VI Proteins 0.000 claims abstract description 43
- 230000003902 lesion Effects 0.000 claims abstract description 13
- 239000000243 solution Substances 0.000 claims description 98
- 210000004027 cell Anatomy 0.000 claims description 76
- 235000015097 nutrients Nutrition 0.000 claims description 55
- 210000001519 tissue Anatomy 0.000 claims description 34
- 230000029087 digestion Effects 0.000 claims description 31
- 238000004132 cross linking Methods 0.000 claims description 27
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 23
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 23
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 23
- 238000011081 inoculation Methods 0.000 claims description 22
- 238000010146 3D printing Methods 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 19
- 102000029816 Collagenase Human genes 0.000 claims description 16
- 108060005980 Collagenase Proteins 0.000 claims description 16
- 229960002424 collagenase Drugs 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 102000004142 Trypsin Human genes 0.000 claims description 12
- 108090000631 Trypsin Proteins 0.000 claims description 12
- 238000007639 printing Methods 0.000 claims description 12
- 239000012588 trypsin Substances 0.000 claims description 12
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical class OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 11
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 11
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 claims description 10
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 claims description 10
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 claims description 10
- 238000005516 engineering process Methods 0.000 claims description 10
- 230000004927 fusion Effects 0.000 claims description 10
- 239000000725 suspension Substances 0.000 claims description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 8
- 210000000172 cytosol Anatomy 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 6
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- 108010003272 Hyaluronate lyase Proteins 0.000 claims description 4
- 102000001974 Hyaluronidases Human genes 0.000 claims description 4
- 238000005345 coagulation Methods 0.000 claims description 4
- 230000015271 coagulation Effects 0.000 claims description 4
- 229960002773 hyaluronidase Drugs 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims description 3
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 229940112869 bone morphogenetic protein Drugs 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 230000012010 growth Effects 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 230000007547 defect Effects 0.000 claims description 2
- 230000001079 digestive effect Effects 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 238000012549 training Methods 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims 8
- 239000000872 buffer Substances 0.000 claims 2
- NLOGSHMIAWCODV-UHFFFAOYSA-N 2-piperazin-4-ium-1-ylethanesulfonate Chemical compound OS(=O)(=O)CCN1CCNCC1 NLOGSHMIAWCODV-UHFFFAOYSA-N 0.000 claims 1
- IGLKELDWPZFFKF-UHFFFAOYSA-N OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.P.P Chemical compound OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.OC(C1=CC=CC=C1C(O)=O)=O.P.P IGLKELDWPZFFKF-UHFFFAOYSA-N 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims 1
- -1 amine glycan Chemical class 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims 1
- 229940099456 transforming growth factor beta 1 Drugs 0.000 claims 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 10
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 10
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 10
- 238000002513 implantation Methods 0.000 abstract description 9
- 230000008439 repair process Effects 0.000 abstract description 8
- 230000007774 longterm Effects 0.000 abstract description 6
- 238000009826 distribution Methods 0.000 abstract description 5
- 230000005847 immunogenicity Effects 0.000 abstract description 4
- 238000000465 moulding Methods 0.000 abstract description 4
- 230000019491 signal transduction Effects 0.000 abstract description 4
- 230000008054 signal transmission Effects 0.000 abstract description 4
- 230000001900 immune effect Effects 0.000 abstract description 3
- 238000010361 transduction Methods 0.000 abstract description 3
- 239000010410 layer Substances 0.000 description 126
- 239000000463 material Substances 0.000 description 20
- 230000006378 damage Effects 0.000 description 15
- 241000283973 Oryctolagus cuniculus Species 0.000 description 14
- 206010007710 Cartilage injury Diseases 0.000 description 11
- 239000007995 HEPES buffer Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000000988 bone and bone Anatomy 0.000 description 8
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 6
- 210000001612 chondrocyte Anatomy 0.000 description 6
- 229920000954 Polyglycolide Polymers 0.000 description 5
- 210000003035 hyaline cartilage Anatomy 0.000 description 5
- 230000028993 immune response Effects 0.000 description 5
- 239000002356 single layer Substances 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 102000055008 Matrilin Proteins Human genes 0.000 description 4
- 108010072582 Matrilin Proteins Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 229960005188 collagen Drugs 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 210000004409 osteocyte Anatomy 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000003716 mesoderm Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000005065 subchondral bone plate Anatomy 0.000 description 2
- 210000001258 synovial membrane Anatomy 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229950003937 tolonium Drugs 0.000 description 2
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 101000844802 Lacticaseibacillus rhamnosus Teichoic acid D-alanyltransferase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000013201 Stress fracture Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000000968 fibrocartilage Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310012363.2A CN103920190B (zh) | 2013-01-14 | 2013-01-14 | 一种关节软骨移植物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310012363.2A CN103920190B (zh) | 2013-01-14 | 2013-01-14 | 一种关节软骨移植物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103920190A CN103920190A (zh) | 2014-07-16 |
CN103920190B true CN103920190B (zh) | 2017-09-29 |
Family
ID=51138728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310012363.2A Expired - Fee Related CN103920190B (zh) | 2013-01-14 | 2013-01-14 | 一种关节软骨移植物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103920190B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI514316B (zh) * | 2014-10-09 | 2015-12-21 | Xyzprinting Inc | 3d模型的關節設置方法、設置設備及其應用程式 |
CN104888275B (zh) * | 2015-04-29 | 2017-07-07 | 陕西瑞盛生物科技有限公司 | 一种软骨细胞膜片的构建方法 |
CN106823006A (zh) * | 2017-01-09 | 2017-06-13 | 中关村竞成细胞及组织工程研究院 | 用于髌骨修复的组织工程骨支架及其制备方法 |
CN106693065B (zh) * | 2017-02-06 | 2019-07-19 | 清华大学深圳研究生院 | 一种梯度组织工程支架制作方法 |
CN107537066B (zh) * | 2017-08-15 | 2020-08-04 | 广东泰宝医疗器械技术研究院有限公司 | 一种基于3d打印的仿生软骨及其制造方法 |
CN111378149B (zh) * | 2018-12-30 | 2021-08-31 | 中国科学院沈阳自动化研究所 | 一种用于3d打印或原位注射的因子缓释中性凝胶系统及其制备方法 |
CN109701079A (zh) * | 2019-01-25 | 2019-05-03 | 上海交通大学医学院附属第九人民医院 | 电纺3d打印制备含同轴静电纺丝多层软骨复合体 |
CN109528358B (zh) * | 2019-02-01 | 2023-11-24 | 北京爱康宜诚医疗器材有限公司 | 软骨替代物 |
US20220298481A1 (en) * | 2021-03-19 | 2022-09-22 | Kaohsiung Medical University | Method for preparing zonal layered chondrocyte sheets and treating method thereof |
CN115154673B (zh) * | 2022-06-28 | 2023-07-14 | 北京航空航天大学宁波创新研究院 | 人工软骨植入物预成型体及制备方法和应用、类生人工软骨植入物胶原纤维原位构建方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7141072B2 (en) * | 1998-10-05 | 2006-11-28 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering |
ITMI20050343A1 (it) * | 2005-03-04 | 2006-09-05 | Fin Ceramica Faenza S R L | Sostituto cartilagineo e osteocindrale comprendente una struttura multistrato e relativo impiego |
EP1948258B1 (en) * | 2005-10-24 | 2013-01-02 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Method and device for synovial cell-charged collagen membrane or gel |
CN101020080A (zh) * | 2007-03-29 | 2007-08-22 | 孔清泉 | 一种关节软骨生物支架材料及制备方法 |
EP2389204B1 (en) * | 2009-01-23 | 2019-07-03 | Royal College of Surgeons in Ireland | Layered scaffold suitable for osteochondral repair |
CN102526806B (zh) * | 2012-01-20 | 2013-12-18 | 陕西博鸿生物科技有限公司 | 一种组织工程软骨及其制备方法 |
-
2013
- 2013-01-14 CN CN201310012363.2A patent/CN103920190B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103920190A (zh) | 2014-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103920190B (zh) | 一种关节软骨移植物及其制备方法 | |
Kundu et al. | An additive manufacturing‐based PCL–alginate–chondrocyte bioprinted scaffold for cartilage tissue engineering | |
Man et al. | Transplantation of allogenic chondrocytes with chitosan hydrogel-demineralized bone matrix hybrid scaffold to repair rabbit cartilage injury | |
Woodruff et al. | The return of a forgotten polymer—Polycaprolactone in the 21st century | |
Kang et al. | In vivo cartilage repair using adipose‐derived stem cell‐loaded decellularized cartilage ECM scaffolds | |
Kang et al. | Poly (lactic-co-glycolic acid) microspheres as an injectable scaffold for cartilage tissue engineering | |
Jiang et al. | Repair of porcine articular cartilage defect with a biphasic osteochondral composite | |
Mertens et al. | Engineering muscle constructs for the creation of functional engineered musculoskeletal tissue | |
CN101020082B (zh) | 一种骨修复材料及其制备方法和用途 | |
US7968026B1 (en) | Three-dimensional bioresorbable scaffolds for tissue engineering applications | |
CN102066558B (zh) | 胞外基质组合物 | |
CN101574540B (zh) | 组织工程骨/软骨双层支架及其构建方法和应用 | |
CN104353111B (zh) | 一种用于腹壁缺损的生物修复材料及其制备方法 | |
CN104307046B (zh) | 一种可注射骨髓间充质干细胞外基质/琼脂糖复合水凝胶及其制备方法和应用 | |
US20070292514A1 (en) | Bioengineered Intervertebral Discs and Methods for Their Preparation | |
CN101934092A (zh) | 用于软骨再生修复的注射型软骨仿生基质材料及使用方法 | |
JP2004504835A (ja) | 組織インプラント | |
CN102526806A (zh) | 一种组织工程软骨及其制备方法 | |
Turnbull et al. | 3D biofabrication for soft tissue and cartilage engineering | |
CN111228574A (zh) | 组织工程半月板支架及其制备方法 | |
Abedi et al. | A collagen–poly (vinyl alcohol) nanofiber scaffold for cartilage repair | |
CN105903079A (zh) | 半月板基质来源的三维多孔海绵状支架、制备方法及应用 | |
CN101890184A (zh) | 一种软骨源性胶原海绵支架及其制备方法 | |
CN106806940A (zh) | 一种掺杂纳米羟基磷灰石的多孔仿生骨支架的制备方法 | |
CN103638553A (zh) | 具有定向通道的透明质酸水凝胶生物支架材料及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 710065 Shaanxi City, south of the Second Ring Road, Qinglong District Albert urban vision, building 11003, No. 1, No. Applicant after: SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Address before: 710065 Shaanxi City, south of the Second Ring Road, Qinglong District Albert urban vision, building 11003, No. 1, No. Applicant before: SHAANXI BOHONG BIOTECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Articular cartilage graft and preparation method thereof Effective date of registration: 20180813 Granted publication date: 20170929 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Registration number: 2018610000125 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190724 Granted publication date: 20170929 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Registration number: 2018610000125 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Articular cartilage graft and preparation method thereof Effective date of registration: 20190809 Granted publication date: 20170929 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Registration number: Y2019980000029 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201103 Granted publication date: 20170929 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIOHONG BIOTECHNOLOGY GROUP Co.,Ltd. Registration number: Y2019980000029 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A articular cartilage graft and its preparation method Effective date of registration: 20201104 Granted publication date: 20170929 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIOHONG BIOTECHNOLOGY GROUP Co.,Ltd. Registration number: Y2020980007531 |
|
TR01 | Transfer of patent right |
Effective date of registration: 20211026 Address after: 710100 19th floor, building 3, Aerospace City Central Plaza, 666 East Chang'an Street, national civil aerospace industry base, Xi'an, Shaanxi Province Patentee after: Xi'an Bohong Biotechnology Co.,Ltd. Address before: 710065 No. 11003, building 1, Weiye City vision, Qinglong community, South Second Ring Road, Xi'an City, Shaanxi Province Patentee before: SHAANXI BIOHONG BIOTECHNOLOGY GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211123 Granted publication date: 20170929 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIOHONG BIOTECHNOLOGY GROUP CO.,LTD. Registration number: Y2020980007531 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170929 |